Impact of State Laws Restricting Opioid Duration on Characteristics of New Opioid Prescriptions

Dave CV, Patorno E, Franklin JM, Huybrechts KF, Sarpatwari A, Kesselheim AS, Bateman BT - Journal of General Internal Medicine

  • Price, Value, and Access
  • Regulation and Clinical Evidence

Summary:

Following implementation of 7-day opioid duration limits for opioid-naïve patients in Massachusetts, Connecticut, and New York in 2016, pooled analysis showed a decreased probability of initiating a >7-day prescription and shorter opioid duration, though without an immediate reduction in total morphine equivalent dose. Between-state heterogeneity was notable, with Massachusetts and Connecticut showing immediate declines in opioid duration while New York’s effect was delayed, suggesting variable implementation and enforcement of these laws across states.

VIEW SOURCE

Recent Work from PORTAL

Simple graphic of magnifying glass examining papers to signify reviewing research publications.

Pharmaceutical Industry Pay-Per-Click Advertising Strategies to Influence Public Opinions on Drug Pricing

Eisenkraft Klein D, Kesselheim AS - Clinical Pharmacology & Therapeutics

  • Price, Value, and Access
Talk bubble graphics representing commentary and opinion.

How Congress Can Fix Expert Advisory Committees

Daval CJR, Kesselheim AS - STAT

  • Regulation and Clinical Evidence
Simple graphic of magnifying glass examining papers to signify reviewing research publications.

Coverage and Costs for Medications After Medicare Price Negotiation

Cai CL, Bucha S, Kesselheim AS, Rome BN - Journal of General Internal Medicine

  • Price, Value, and Access